Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
17.20
+1.00 (6.17%)
At close: Sep 2, 2025
6.17%
Market Cap1.79B
Revenue (ttm)428.63M
Net Income (ttm)46.56M
Shares Out103.81M
EPS (ttm)0.45
PE Ratio38.10
Forward PEn/a
Dividend0.10 (0.62%)
Ex-Dividend DateDec 9, 2024
Volume2,059,975
Average Volume1,068,156
Open16.20
Previous Close16.20
Day's Range16.10 - 17.60
52-Week Range12.60 - 20.80
Beta0.28
RSI64.92
Earnings DateNov 25, 2025

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 313
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SILCOPHL
Full Company Profile

Financial Performance

In 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.

Financial Statements

News

There is no news available yet.